CD34 and acute myeloid leukemia: We found that Wnt/β‐catenin/CBP inhibition by the molecules PRI‐724 or iCRT3 increased the phenotypic CD34+GPR56+ LSC fraction in the PDX sample AML‐661 (Appendix Fig S4B).